Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib for pain after abdominal hysterectomy
2008-004867-21Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in postoperative pain (3 arms), sponsored by Merck & Co. Primary endpoints: Pain intensity at rest over Days 1 to 3, Average daily morphine dose over Days 1 to 3 and 1 more. Started Sep 2008; status: completed.
02
Drugs
etoricoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-004867-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004867-21.